Scientific Online Resource System

Actual Nephrology

Achieving a Longer Duration of Peritoneal Dialysis Replacement Treatment in Patients with CKD

Darina Damyanova, Boryana Ivanova, Svetla Staykova, Rossitsa Zorchevа

Abstract

INTRODUCTION: The International Society for Peritoneal Dialysis (ISPD) and the European Peritoneal Dialysis Association (EuroPD) recommend peritoneal dialysis (PD) as an initial replacement therapy for renal function due to a number of benefits of the method for both patients and the treatment team, health funds and society as a whole. It would be in everyone's interest to achieve a longer duration of PD treatment. For each dialysis center, the first step in this direction should be to identify the most common reasons for termination of PD. The next step is to develop a strategy to eliminate them or reduce their frequency based on the recommendations of the EuroPD and ISPD for best clinical practice in the field of PD.
AIM: The aim of this article is to analyze the reasons for discontinuation of treatment with PD and to outline opportunities for their elimination in order to achieve a longer duration of treatment with PD leading to longer overall life expectancy of patients. PATIENTS AND METHODS: During the period 01.01.2010–31.12.2019 patients were observed in the Clinic of Nephrology and Dialysis of the St. Marina University Hospital, Varna. The group consisted of 82 patients with CKD on replacement therapy with PD, aged 20 to 79 years—42 women and 40 men, with a duration of treatment of 3 to 108 months. The reasons for discontinuation of the PD treatment were analyzed. The EuroPD and ISPD recommendations for best clinical practice in the field of PD related to the targets are summarized.
RESULTS AND DISCUSSION: Of the 82 patients included in the study, as of December 31, 2019, 18 patients continue treatment with PD, 35 have switched to hemodialysis (HD), 8 have been transplanted, and 21 have died. The most common reason for transfer to HD is impaired peritoneal membrane function with reduced removal of waste products of protein metabolism and ultrafiltration (UF) deficiency. It is followed by peritonitis, catheter-associated infections and other reasons, incl. non-medical. The most common causes of death are cardiovascular complications—cerebrovascular disease (stroke), ischemic heart disease (heart attack), heart failure. Recurrent peritonitis and catheter-related infections are next in frequency. In some patients the cause of death remains unknown. Some of the reasons for stopping treatment could be eliminated, and for others it is probably possible to reduce their frequency.
CONCLUSION: In conclusion, in order to achieve a longer duration of treatment with PD, the efforts of the treatment team should be focused on 3 main areas: (1) preservation of peritoneal membrane function and its periodic examination for timely diagnosis of changes in it; (2) development and implementation of a strategy for prevention of peritonitis and catheter-related infections, and (3) monitoring and timely treatment of hypertension, hyperlipidemia, and hyperhydration as major risk factors for cardiovascular pathology.


Keywords

peritoneal dialysis, peritoneal membrane, peritonitis, hypertension

Full Text


References

Fusshoeller A. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis. Pediatric Nephrology. 2008; 23:19–25. doi: 10.1007/s00467-007-0541-z

Parikova A, Hruba P, Krejcik Z, Franekova J et all. Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes. 2020. https://doi.org/10.1152/ajprenal.00274.2019

Bernard G Jaar, Laura C Plantinga, Deidra C Crews, Nancy E Fink, Nasser Hebah, Josef Coresh, Alan S Kliger, and Neil R Powe. Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study. BMC Nephrol. 2009; 10: 3. Published online 2009 Feb 6. doi: 10.1186/1471-2369-10-3

Brown E, Blake P, Boudville N, Davies S et al. International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Peritoneal Dialysis International Online First, 2020, https://doi.org/10.1177/0896860819895364

Li Ph K-T et all. Tackling Dialysis Burden around the World: A Global challenge. Kidney Dis 2021;7:167–175, DOI: 10.1159/000515541

Зорчева Р. Избор на ПД за начална заместителна терапия на бъбречната функция (гл.ХV). В: „Заместителна терапия на бъбречната функция с перитонеална диализа – съвременна клинична стратегия“ ,2013, стр. 104–112.

Van Diepen A.T.N., Coester A.M., Janmaat C.J, Dekker F.W., Struijk D.G., Krediet R.T. Comparison of longitudinal membrane function in PD patients according to dialysis fluid biocompatibility. Kydney Int Rep 2020, 5, 2183-2194.

Gotloib L. Preservation and modulation of peritoneal function. In: Contribution to nephrology vol 163, Peritoneal dialysis from basic concept to clinical excellence, 2009: 74-81.

Panzer S., Teitelbaum I. Alternative dialysis strategies with Iсodextrin. In: Ronco C, Rosner MH, Crepaldi C (eds): Peritoneal dialysis – State-of-the-art 2012. Contrib Nephrol. Basel, Karger, 2012, vol 178, 11-15.

Van Biesen W, Heimburger O, Krediet R, Rippe B, La Milia V, Covic A, Vanholder R and for the ERBP working group on peritoneal dialysis. Evaluation of peritoneal membrane characteristics: a clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant 2010, 25: 2052–2062, doi: 10.1093/ndt/gfq100

Morelle J, Stachowska-Pietka J, Öberg C. et all. ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: Classification, measurement, interpretation and rationale for intervention. https://doi.org/10.1177/0896860820982218 (First Published February 10, 2021)

Guest St. PD in special situations. In: Handbook of peritoneal dialysis. 2010: 207-217.

Tong DC, Walker RJ. Antibiotic prophylaxis in dialysis patients undergoing invasive dental treatment. Nephrology 2004, 9:167-170.

D.Y.H. Yap, K.C. Tse, M.F. Lam, T.M. Chan and K.N. Lai. Polymicrobial CAPD Peritonitis After Hysteroscopy Perit Dial Int 2009, 29(2): 237-238.

Li PKT, Leung CB, Leung AKL, Luk WK, Lai KN. Posthysteroscopy fungal peritonitis in a patient on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 21: 446-448.

Wang X, Axelsson J, Lindholm B, et al. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients. Blood Purif. 2005;23:373–378. (100,101)

Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, et al. The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2005;20:1693–701.

Yamamoto T, Nakayama M, Miyazaki M, et al. Relationship between low blood pressure and renal/cardiovascular outcomes in japanese patients with chronic kidney disease under nephrologist care: the gonryo study. Clin Exp Nephrol. 2015;19:878–86.

Sarafidis PA, Persu A, Agarwal R, et al. Hypertension in dialysis patients: a consensus document by the european renal and cardiovascular medicine (EURECA-M) working group of the european renal association-european dialysis and transplant association (ERA-EDTA) and the hypertension and the kidney working group of the european society of hypertension (ESH). Nephrol Dial Transplant. 2017;32:620–40.

Wang AY, Brimble KS, Brunier G, et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part i - assessment and management of various cardiovascular risk factors. Perit Dial Int. 2015;35:379–87.

Hirakata H, Nitta K, Tomo T, et al. Clinical guidelines for the evaluation and the treatment of cardiovascular complications in hemodialysis patients. J Jpn Soc Dial Ther. 2011;44:337–425 (in Japanese).

Ito Y, Munekazu Ryuzaki M, Sugiyama H et al. Peritoneal Dialysis Guidelines 2019 Part 1 (Position paper of the Japanese Society for Dialysis Therapy). Renal Replacement Therapy volume 7, Article number: 40 (2021) – https://doi.org/10.1186/s41100-021-00348-6




DOI: http://dx.doi.org/10.14748/an.v16i1.8467

Refbacks

About The Authors

Darina Damyanova
Clinic of Nephrology and Dialysis, St. Marina University Hospital Varna, Мedical University of Varna
Bulgaria

Boryana Ivanova
Clinic of Nephrology and Dialysis, St. Marina University Hospital Varna, Мedical University of Varna
Bulgaria

Svetla Staykova
Clinic of Nephrology and Dialysis, St. Marina University Hospital Varna, Мedical University of Varna
Bulgaria

Rossitsa Zorchevа
Clinic of Nephrology and Dialysis, St. Marina University Hospital Varna, Мedical University of Varna
Bulgaria

Font Size


|